(November 17, 2023, 11:58 AM EST) -- WASHINGTON, D.C. — The Patent Trial and Appeal Board did not err in rejecting allegations of obviousness and anticipation by Medtronic Inc. in an inter partes review (IPR) of a patented guide extension catheter, the Federal Circuit U.S. Court of Appeals ruled Nov. 16....